Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Share-based Compensation: 2014-2025

Historic Share-based Compensation for Veracyte (VCYT) over the last 11 years, with Sep 2025 value amounting to $10.8 million.

  • Veracyte's Share-based Compensation rose 22.98% to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.3 million, marking a year-over-year increase of 24.02%. This contributed to the annual value of $36.2 million for FY2024, which is 9.38% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Share-based Compensation is $10.8 million, which was down 2.08% from $11.0 million recorded in Q2 2025.
  • Veracyte's Share-based Compensation's 5-year high stood at $11.0 million during Q2 2025, with a 5-year trough of $3.9 million in Q1 2021.
  • For the 3-year period, Veracyte's Share-based Compensation averaged around $9.3 million, with its median value being $9.6 million (2024).
  • As far as peak fluctuations go, Veracyte's Share-based Compensation spiked by 154.71% in 2021, and later dropped by 7.44% in 2022.
  • Over the past 5 years, Veracyte's Share-based Compensation (Quarterly) stood at $6.7 million in 2021, then climbed by 2.01% to $6.9 million in 2022, then climbed by 9.39% to $7.5 million in 2023, then climbed by 28.18% to $9.6 million in 2024, then climbed by 22.98% to $10.8 million in 2025.
  • Its Share-based Compensation stands at $10.8 million for Q3 2025, versus $11.0 million for Q2 2025 and $11.0 million for Q1 2025.